Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify whether or not the addition of a numbing medicine
that is injected directly into the site of the bone marrow procedure can reduce pain and the
use of opioid pain medication after bone marrow procedures. The addition of this medicine,
called ropivacaine, is the experimental part of this study. This is the first time
ropivacaine will be directly injected into the bone marrow site at MSKCC Pediatrics.